QuadraMed Launches ICD-10 Countdown Program at AHIMA 2009

The Quantim ICD-10 Coding Simulator will be available for hands-on demonstrations at the 81st AHIMA Convention & Exhibit taking place October 3-8, 2009 in Grapevine, Texas. Pre-conference interest in the new product has been high, with almost 100 requests for product demonstrations of the coding simulator. AHIMA's e-HIM(R) Virtual Laboratory, funded by the organization's research and education Foundation, is using QuadraMed's ICD-10 Coding Simulator throughout the year to train coding students, reaching approximately 170 schools and over 4,000 students nationwide. QuadraMed was the first in the industry to deploy an ICD-10 Coding Simulator for coder training in the e-HIM Virtual Lab.

According to the Deloitte Center for Health Solutions, ICD-10 implementation has the potential to surpass Y2K in both total impact and cost as it drives the evolution of the global healthcare system. "AHIMA's adoption of our ICD-10 Countdown Program delivers a strong message to health information management (HIM) professionals that it's critical to begin now to ensure a successful ICD-10 transition -- a transition that will impact almost all clinical, financial and HIM systems in use today," said Duncan W. James, president and CEO of QuadraMed. "Our ICD-10 Countdown Program provides coders with the hands-on training and educational services required to gain familiarity with the new ICD-10 coding methodology."

QuadraMed's ICD-10 Countdown Program provides clients access to software, training and educational tools to assist with the transition from ICD-9 to ICD-10 code sets. QuadraMed's ICD-10 Countdown Program includes:

-- Quantim(R) ICD-10 Coding Simulator with an introductory 90-day subscription

-- ICD-10 fundamentals educational tool

-- Online application tutorial, "Countdown to ICD-10"

-- Participation in QuadraMed's ICD-10 community bulletin board

The U.S. healthcare industry has used ICD-9 Clinical Modification (ICD-9-CM) code sets to encode diagnoses and procedures since the late 1970s. Per the Senate Bill 628, the United States will finally adopt the ICD-10 system, which has already been implemented worldwide with the exception of the United States. U.S. healthcare organizations must now convert from ICD-9 to ICD-10 by the compliance date of October 1, 2013 or risk losing claims reimbursement from The Centers for Medicare & Medicaid Services (CMS).

The challenge of the ICD-10 transition lies within its complexity and dramatic increase in the number of code sets. For example, the number of disease classifications will rise from 13,000 ICD-9-CM to 68,000 ICD-10-CM codes. For procedure classifications, the number of codes will expand from 3,000 ICD-9-PCS to 78,000 ICD-10 PCS codes.

"The transition to ICD-10 will allow healthcare organizations to capture greater documentation detail for coding, resulting in increased accuracy in data reporting and reimbursement, as well as consistent compliance with regulatory and quality reporting requirements. As all U.S. hospitals will be required to make this coding conversion, QuadraMed foresees an increased demand for our products and services as healthcare organizations look to us to help them assess their readiness, train staff and implement ICD-10 compliant solutions," added James.

The ICD-10 Countdown Program will be available to hospitals, medical groups, consultants and medical coding groups within the United States. For more information, visit www.quadramed.com/icd-10.

About QuadraMed Corporation

QuadraMed(R) -- (NASDAQ:QDHC) is a leading provider of healthcare technologies and services that help turn quality care into positive financial outcomes. QuadraMed provides innovative solutions that streamline processes, ensure compliance and help healthcare professionals deliver quality patient care. Behind the Company's products and services is a staff of 600 professionals whose experience and dedication have earned QuadraMed the trust and loyalty of clients at over 2,000 healthcare provider facilities. For more information about QuadraMed, visit http://www.quadramed.com.

Cautionary Statement on Risks Associated with QuadraMed Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. The words "believe," "expect," "target," "goal," "project," "anticipate," "predict," "intend," "plan," "estimate," "may," "will," "should," "could" and similar expressions and their negatives are intended to identify such statements. Forward-looking statements are not guarantees of future performance, anticipated trends or growth in businesses, or other characterizations of future events or circumstances and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks faced by QuadraMed described in documents filed with the Securities and Exchange Commission ("SEC") from time to time. QuadraMed's SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC's EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).

QuadraMed is a registered trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.

SOURCE: QuadraMed Corporation

Kate Donlon 
Amendola Communications for QuadraMed Corporation 
619-876-2654 
kdonlon@ACMarketingPR.com 
or 
Investor Relations 
703-742-5393 
InvestorRelations@QuadraMed.com